https://ipopi.org/wp-content/uploads/2024/03/2.png
720
1200
IPOPI
https://ipopi.org/wp-content/uploads/2017/06/LOGO.svg
IPOPI2024-03-18 16:23:372025-01-08 14:26:20Three Newly Published IPOPI Information Leaflets
https://ipopi.org/wp-content/uploads/2024/03/IPOPI_HyperIGM_2023_Cover.jpg
2480
1748
IPOPI
https://ipopi.org/wp-content/uploads/2017/06/LOGO.svg
IPOPI2024-03-18 12:20:362024-03-18 12:31:29Management of Hyper IgM Syndromes
https://ipopi.org/wp-content/uploads/2024/03/IPOPI_SCID_2023_Cover.jpg
2480
1748
IPOPI
https://ipopi.org/wp-content/uploads/2017/06/LOGO.svg
IPOPI2024-03-18 12:19:592024-03-26 10:24:58The Management of Severe Combined Immunodeficiency (SCID)
https://ipopi.org/wp-content/uploads/2024/03/IPOPI_WarningSIgns_2023_Cover.jpg
2480
1748
IPOPI
https://ipopi.org/wp-content/uploads/2017/06/LOGO.svg
IPOPI2024-03-18 12:19:262024-03-18 12:35:54PID Warning Signs Across Medical Specialties
https://ipopi.org/wp-content/uploads/2024/03/IG-vials-1-scaled.jpg
1700
2560
IPOPI
https://ipopi.org/wp-content/uploads/2017/06/LOGO.svg
IPOPI2024-03-12 09:54:502025-01-08 14:30:11New statement: Patients with PIDs should have access to safe, efficacious and high-quality immunoglobulin therapies
